CDK 4/6 Inhibitors in Metastatic Breast Cancer

1 Visninger
administrator
administrator
07/03/23

Hope S. Rugo, MD, discusses the use of CDK 4/6 inhibitors and their impact on the treatment paradigm for metastatic breast cancer.

  • Kategori

Vis mere

0 Kommentarer Sorter efter

Ingen kommentarer fundet

Facebook kommentarer

Nรฆste